
Akilos-P Tab
UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Linagliptin 5 mg
Type 2 diabetes mellitus: used to improve glycaemic control in adults, as monotherapy or in combination with other antidiabetic medicines along with diet and exercise.
Linagliptin is a DPP-4 inhibitor. It increases levels of incretin hormones (GLP-1 and GIP), which enhance glucose-dependent insulin release and reduce glucagon secretion, lowering blood glucose with a low risk of hypoglycaemia when used alone.
Oral tablet. Usual adult dose: 5 mg once daily, with or without food, at the same time each day. Swallow whole with water. Dose adjustments and combination therapy should be as advised by a doctor.
Common side effects of Lglip 5 Tab may include:

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery
UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 mg - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery

UNISON PHARMACEUTICALS - tablet - 10 S
Standard delivery
Not for type 1 diabetes or diabetic ketoacidosis. Stop and seek medical help if symptoms of pancreatitis occur (severe persistent abdominal pain). Rare severe joint pain and hypersensitivity/angioedema may occur. Monitor for hypoglycaemia when combined with insulin or sulfonylureas (dose reduction of those agents may be needed). Use with caution in severe hepatic impairment; generally no renal dose adjustment needed for linagliptin, but follow physician advice. Inform doctor about history of pancreatitis.